Skip to content
10-Q

Quarterly Report

STRONGBRIDGE BIOPHARMA plc

0001558370-21-006869

← back to feed
Filed
May 12, 2021 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 10, 2021 67.59M sh
Shares Diluted Q1 2021 · Mar 31, 2021 67.38M sh
Shares Diluted Q1 2021 · Mar 31, 2020 54.44M sh
Capex Q1 2021 · Mar 31, 2021 $10K
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$13.39M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$15.24M
Long Term Debt Q1 2021 · Mar 31, 2021 $17.4M
Long Term Debt Q1 2021 · Dec 31, 2020 $17.11M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $73.9M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $87.52M
Stockholders Equity Q1 2021 · Mar 31, 2021 $55.85M
Stockholders Equity Q1 2021 · Dec 31, 2020 $65.61M
Stockholders Equity Q1 2021 · Mar 31, 2020 $61.18M
Stockholders Equity Q1 2021 · Dec 31, 2019 $72.19M
Current Liabilities Q1 2021 · Mar 31, 2021 $21.98M
Current Liabilities Q1 2021 · Dec 31, 2020 $21.13M
Total Liabilities Q1 2021 · Mar 31, 2021 $52.2M
Total Liabilities Q1 2021 · Dec 31, 2020 $55.5M
Current Assets Q1 2021 · Mar 31, 2021 $79.66M
Current Assets Q1 2021 · Dec 31, 2020 $92.35M
Total Assets Q1 2021 · Mar 31, 2021 $108.05M
Total Assets Q1 2021 · Dec 31, 2020 $121.1M
Eps Diluted Q1 2021 · Mar 31, 2021 −$0.18
Eps Diluted Q1 2021 · Mar 31, 2020 −$0.24
Eps Basic Q1 2021 · Mar 31, 2021 −$0.18
Eps Basic Q1 2021 · Mar 31, 2020 −$0.23
Sga Expense Q1 2021 · Mar 31, 2021 $10.95M
Sga Expense Q1 2021 · Mar 31, 2020 $10.4M
Rd Expense Q1 2021 · Mar 31, 2021 $5.84M
Rd Expense Q1 2021 · Mar 31, 2020 $7.55M
Net Income Q1 2021 · Mar 31, 2021 −$11.81M
Net Income Q1 2021 · Mar 31, 2020 −$12.7M
Operating Income Q1 2021 · Mar 31, 2021 −$10.07M
Operating Income Q1 2021 · Mar 31, 2020 −$13.51M
Revenue Q1 2021 · Mar 31, 2021 $8.38M
Revenue Q1 2021 · Mar 31, 2020 $6.67M